Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
58 Cards in this Set
- Front
- Back
i. What is the clinical use for amphotericin B?
|
1. Broad-spectrum antifungal drug
2. Effective for most fungal infections 3. Used for serious and progressive infections |
|
ii. What are the adverse effects of amphotericin B?
|
1. NEPHROTOXIC
|
|
iii. What are the four formulations of amphotericin B?
|
1. Amphotericin B deoxycholate
2. Amphotericin B lipid complex (ABLC) 3. Amphotericin B cholesteryl sulfate complex (ABCD) 4. Liposomal formulaton of amphotericin B |
|
What is the advantage of lipid formulations of amphotericin B over deoxycholate?
|
Less nephrotoxic
|
|
What is the MOA of amphotericin B?
|
1. Binds to ergosterol
2. Causes pore formation |
|
What is the bioavailability of amphotericin B?
|
1. Poor
2. Poor absorption |
|
How is amphotericin B administered?
|
IV
|
|
Why is amphotericin B so effective?
|
Liposomal formulations transfer amphotericin B to fungal membranes and less to human membranes
|
|
What drug interactions should you be wary of with amphotericin B?
|
1. Other nephrotoxic drugs
2. Amphotericin B + Flucytosine |
|
What does amphotericin B+Flucytosine yield?
|
They potentiate one another so are more toxic when used together and the dosage should be reduced
|
|
What are the benefits of combination use?
|
1. Decreased resistance
2. Drug A can kill things that Drug B cannot |
|
What are the clinical uses of Azole and itraconazole?
|
Broad-spectrum antifungal agents
|
|
What do imidazoles and triazoles bind in their MOA?
|
1. P450 enzymes (fungi version preferentially)
2. Inhibit ergosterol synthesis |
|
Which is safer, amphotericin B or itraconazole?
|
Itraconazole
|
|
What is the route of administration for itraconazole?
|
Oral
|
|
What are the adverse effects of itraconazole?
|
1. Liver toxicity
2. Cardiosuppression (H+ inhibitor) |
|
Ketoconazole is not used very much. Why?
|
High hepatotoxicity
|
|
What is the clinical use of ketoconazole?
|
Broad spectrum anti fungal agent.
Safer than amphotericin B |
|
What is the administration of ketoconazole?
|
Oral
|
|
What are the adverse effects of ketoconazole? How do you combat these effects?
|
1. Hepatotoxicity
2. Monitor liver function before and during treatment |
|
What is the MOA for azoles?
|
1. Inhibit ergosterol synthesis
2. Bind to cytochrome P450 enzymes |
|
Why are triazoles a “good azole”?
|
1. Fewer side effects
2. Better absorption 3. Better drug distribution 4. Fewer drug interactions |
|
What do itraconazole and ketoconazole inhibit?
|
1. CYP3A4 (450)
|
|
What decreases the absorption of itraconazole?
|
1. Drugs that raise gastric pH
2. H2 antagonists 3. Proton pump inhibitors |
|
What is the MOA of fluconazole?
|
Inhibits cytochrome P450 syndrome
|
|
What does fluconazole inhibit?
|
Cytochrome P450 CYP3A4
|
|
What are the adverse effects of fluconazole?
|
1. Some Nausea, but generally well tolerated
3. Rare hepatotoxicity 4. May be associated with Stevens-Johnson syndrome 5. May be teratogenic |
|
What is flucytosine converted to, and where does it take place?
|
5-FU, in Fungal cells
|
|
After flucytosine is converted to 5-FU, what is 5-FU converted to?
|
1. FdUMP→ inhibits DNA synthesis
|
|
What is the MOA of echinocandins?
|
1. Inhibit synthesis of beta-1,3-D-glucan
2. Block synthesis of cell wall components in fungal membranes |
|
What is the administration of echinocandins?
|
IV
|
|
What are echinocandins approved for?
|
1. Aspergillosis in patients unresponsive or intolerant to other drugs
2. Systemic Candida infections |
|
What are the four classes of drugs used for superficial mycoses?
|
i. Azoles
ii. Griseofulvin iii. Polyene antibiotics iv. Allyamines |
|
How are azoles formulated for superficial mycoses?
|
1. Topical
2. Oral |
|
What is the most effective formulation of clotrimazole?
|
1. Topical
2. Tinea pedis…. |
|
What can clotrimazole be used for? In what parts of the body?
|
1. Dermatophytic infections and candidiasis
2. Skin, mouth, and vagina |
|
What are the adverse effects of Clotrimazole? (skin and intravaginal)
|
1. Skin→ stinging, erythema, edema
2. Intravaginal→ burning and lower abdominal cramps |
|
Against what type of infection is Griseofulvin active? Inactive?
|
1. Active against superficial dermatophytic infections
2. Inactive against candidiasis and systemic infections |
|
What is the MOA of Griseofulvin?
|
1. Deposited in keratin of skin, hair, and nails
2. Inhibits fungal mitosis by binding components of mcirotubules |
|
What is the availability of Griseofulvin?
|
Oral
|
|
What are the polyene antibiotics?
|
i. Amphotericin B
ii. Nystatin |
|
What is the clinical use of nystatin?
|
Topical for candidiasis
|
|
What is the MOA of Nystatin?
|
Binds ergosterol
|
|
What is the availability of nystatin?
|
Oral and topical
|
|
What is the toxicity of nystatin?
|
i. Very low only when used topically
ii. Too toxic by parenteral injections |
|
What is the clinical use of naftifine?
|
Topical treatment of dermatophyte infections
|
|
What is the MOA of naftifine?
|
i. Inhibits the enzyme squalene epoxidase
ii. Decreases ergosterol iii. Fungicidal |
|
What is ciclopirox used for?
|
i. Broad spectrum
ii. Skin and nail infections? |
|
What is the MOA of ciclopirox?
|
Chelates iron and aluminum
|
|
What is tolnaftate used for?
|
i. Dermatophytes, not Candida
ii. Treatment of tinea pedis, tinea cruris, tinea corporis |
|
What is the MOA of tolnaftate?
|
Unknown
|
|
Why may systemic formulation be favored over topical formulation?
|
a. Systemic may be more effective because it can cover disseminated systemic infections
|
|
What are some general drawbacks of systemic formulations?
|
a. Antifungals have toxicity issues
|
|
Why might topical be better than systemic formulation?
|
a. Topical reduces adverse effects and may be effective
|
|
A patient undergoes a round of an azole and hasn’t completely responded. What drug should they switch to?
|
Echinocandins
|
|
What drug has negative inotropic action?
|
Itraconazole
|
|
Is resistance to flucytosine common?
|
Yes
|
|
What drug can decrease levels of immunosuppresant drugs?
|
Caspofungin
|